Delivery Order SPE2DB22D3016-SPE2DB25FAWJ2

Award Date 5/13/25
Potential Completion Date 5/14/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a $121,212.48 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product. This delivery order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of $999,999,999 and runs through...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the provision of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The total ceiling value of the contract is $1,012.32, with a period of performance ending on June 14, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,064.40, is for the delivery of 4,568,032,429 units of the BOOSTRIX TDAP vaccine syringe (0.5 mL). The contract is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of April 28, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML. The $2,342.70 contract has a period of performance through February 4, 2025. This Delivery Order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a wide...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $1,392.25 and a completion date of May 2, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a ceiling value of $4,745.88 and a period of performance through March 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, worth $2,299.20, is for the provision of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML to support military healthcare programs. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999, which serves as a primary vehicle for AmerisourceBergen to supply a comprehensive range of pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of BOOSTRIX TDAP vaccine syringes. The contract has a ceiling value of $38,903.16 and runs through April 7, 2025. It is a firm fixed-price contract, with no set-aside designation indicated. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,612.30 firm fixed-price contract is for the delivery of BOOSTRIX TDAP vaccine syringes, 0.5 ml, with a performance period ending on May 7, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which enables...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, a vaccine product, with a ceiling value of $28,248.90. The contract is a firm fixed-price delivery order with a performance period through May 9, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DB22D3016
    Indefinite Delivery Contract
  • SPE2DB22D3016-SPE2DB25FAWJ2
    Delivery Order

This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of the BOOSTRIX TDAP VACCINE SYRINGE 0.5ML, with a total ceiling value of $2,359.64. The contract has an ultimate completion date of May 14, 2025.

This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle for the Defense Health Agency, U.S. Coast Guard, and other government agencies. The contract allows for multiple delivery orders across different therapeutic categories, positioning Amerisourcebergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems.

The contract is not designated as a set-aside, indicating open competition. No subcontractors are mentioned in the information provided.

Generated 8/17/25, 1:05 AM